BackFidelity Advisor Biotechnology Fund Overview
Fidelity Advisor Biotechnology Fund

Fidelity Advisor Biotechnology Fund Return on Equity

Fidelity Advisor Biotechnology Fund (FBTIX) has a ROE of 40.73%, above the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

40.73%

Return on Equity

40.73%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Fidelity Advisor Biotechnology Fund (FBTIX) FAQ

The latest ROE for FBTIX is 40.73%. That is above the sector sector average of 11.85%. Investors often review this figure alongside Fidelity Advisor Biotechnology Fund's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, FBTIX currently prints 40.73% for ROE, while the sector average sits near 11.85%. That is roughly 243.6% above the sector mean. Large gaps often invite a closer look at Fidelity Advisor Biotechnology Fund's growth, margins, and balance sheet.

Return on Equity shows how effectively Fidelity Advisor Biotechnology Fund converts resources into returns. At 40.73%, FBTIX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FBTIX's ROE (40.73%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.